Dry Eye Disease is a chronic condition characterized by inadequate lubrication of the eyes caused by tear film instability. While some dry eye risk factors include age, menopause, and specific medications, dry eye disease is often exacerbated by digital screen use. Indeed, phones, tablets, and computers have led us to the point where studies estimate that over 60% of office workers who use smartphones or computers1 suffer from dry eyes. Artificial tears are a go-to solution for managing the condition, but not all eye drops work the same way. Because their formulations vary, some options may be better suited to address symptoms and needs.
The Reapplication Challenge

While eye drops can be effective, a common challenge users face is how often they need to reapply. Lubricants don’t always last very long on the surface of the eye because of natural defence mechanisms. Tear drainage and blinking can limit effectiveness. Additionally, the fact that there is a limit to how much volume can be placed on the eye, the cul-de-sac, also known as the space between the eyelid and the eyeball, can only accommodate so much.
The Role of Viscosity
So, what’s the scientific solution to all of this? Viscosity. Viscosity describes how thick or resistant to flow a fluid is. In ocular lubricants, viscosity plays a major role in determining residence time on the eye’s surface. When aiming for a long-lasting eye drop, a formulation that is highly viscoadaptive, like the I-DROP® line, is desired. In fact, this type of formulation is particularly beneficial when considering that ocular lubricants should have a higher viscosity than natural tears, as they become diluted once instilled in the eye.

Higher viscosity formulations tend to:
- Increase retention time on the eye
- Provide more sustained hydration
- Better resist drainage and evaporation
Formulations with optimized viscosity and viscoadaptive behavior may increase ocular-surface residence time, improve tear-film stability, and reduce the need for frequent reapplication. Because highly viscous formulations can cause some blurring, formulation design must balance retention, comfort, and visual clarity. With viscoadaptive products like I-DROP® PUR and I-DROP® PUR GEL, your eye gets recoated with every blink, which makes your artificial tears last longer and provide increased comfort by reducing the need for re-application.
Measuring Performance: Tear Break Up Time (TBUT)
TBUT (Tear Break Up Time)2 is s a clinical measure of tear-film stability. Shorter TBUT may reflect increased evaporation, lipid-layer dysfunction, aqueous deficiency, or other tear-film dynamics. It’s done by putting topical fluorescein into the eyes. Mathers and Lane have claimed, “… tear film stability actually refers primarily to evaporation rate; a stable tear film is one in which a minimum amount of tears evaporates.”3
Evaporation occurs when the tear film becomes unstable, either from reduced aqueous layer production by the lacrimal glands or decreased oil (meibum) secretion from the meibomian glands, which weakens the lipid layer. When either of these processes occurs, it leads to rapid evaporation and tear film breakup. Professionals can assess tear-film stability to evaluate dry eye.
When it comes to understanding TBUT results, the general benchmarks are as follows:

Indeed, the longer it takes, the more stable the tear film is. When it is not prioritized or managed, however, instability can lead to:
- Increased ocular surface irritation
- Inflammation of the cornea and conjunctiva
- Blurred vision
- Discomfort during everyday activities including prolonged digital device use
To assess tear film stability properly, researchers used the Ocublink System during the study “Evaluating Viscosity and Tear Breakup Time of Contemporary Commercial Ocular Lubricants on an In Vitro Eye Model” to analyze the tear film stability of several popular artificial tears. These industry comparisons help illustrate where products in the dry eye management market stand in relation to one another.


A Smarter Approach to Artificial Tears
Offering a range of high-viscosity dry eye drops, the I-DROP® line of preservative-free artificial tears stands out as a strong option. In fact, the test showed that:
- The I-DROP® line exhibits high initial viscosity offering an extended TBUT while behaving like the natural tear film.
- The I-DROP® line mimics natural tear film, offering comfort during blinking.
- I-DROP® uses a unique formula that contains high molecular hyaluronic acid to improve tear stability and mimic natural tear viscosity
Ultimately, managing dry eye effectively isn’t just about using artificial tears, it’s about choosing a formulation designed to truly support the tear film. The science behind viscosity and tear film stability shows that the right formulation can make a meaningful difference in both comfort and performance.
This is where the I-DROP® line stands apart. With viscoadaptive properties designed to maintain stability on the ocular surface and extend tear breakup time, these formulations are built to deliver lasting relief where many conventional drops fall short.
For those looking for a solution that goes beyond temporary lubrication, the I-DROP® line represents a smarter, science-driven approach to dry eye management, helping support healthier, more stable tears with every blink.
Think you might have dry eyes?
To discover I-MED Pharma’s line of OSD solutions, shop now!
To learn more about carrying I-MED products in your clinic, contact us today!
References
- Phan CM, Ross M, Chan VWY, et al. Evaluating Viscosity and Tear Breakup Time of Contemporary Commercial Ocular Lubricants on an In Vitro Eye Model Translational Vision Science & Technology. 2023;12(12):8. doi:10.1167/tvst.12.12.8. https://tvst.arvojournals.org/article.aspx?articleid=2791258
- Noda K, Takahashi Y, Nishida K. Easy and effective test to evaluate tear-film stability for self-diagnosis of dry eye syndrome: blinking tolerance time (BTT). BMC Ophthalmology. 2020;20:437. doi:10.1186/s12886-020-01686-2. https://pmc.ncbi.nlm.nih.gov/articles/PMC7640480/
- Mathers WD, Lane JA. Meibomian gland lipids, evaporation, and tear film stability. Adv Exp Med Biol. 1998;438:349–360. doi:10.1007/978-1-4615-5359-5_50. https://doi.org/10.1007/978-1-4615-5359-5_50